Emcure pharmaceuticals launches its Over-The-Counter (OTC) portfolio with the brand: Galact
Made from natural ingredients like Shatavari and 6 other herbs, Galact is a lactation supplement that helps boost the production of breast milk for mothers and is associated with improvement of immunity and IQ for the babies.
Supports all mothers for exclusive breastfeeding for first 6 months (100%) as per WHO & UNICEF guidelines
Emcure Pharmaceuticals, one of India’s leading pharmaceutical company which has a strong focus on women’s healthcare, announces its entry into the over-the-counter (OTC) market, with their product Galact. Prescribed by healthcare professionals for more than 20 years, Galact will now also be available as an over-the-counter (OTC) offering.
With a significant shift of the consumers opting for herbal and ayurvedic products over chemical-based product, the brand Galact is enriched with the potency of Shatavari and six other herbs. Galact is meticulously formulated to boost breast milk production for mothers. Shatavari is also known to enhance baby’s weight, sleep pattern, leading to better immunity, while a key ingredient, Yashtimadhu, helps in enhancing cognitive function, memory, and concentration, thereby assisting in improving baby’s IQ. Following the launch of Galact, Emcure will be able to introduce a diverse array of OTC products catering to the unique needs of women.
Speaking on the occasion, Ms. Namita Thapar, Whole-time Director, Emcure Pharmaceuticals said, “Emcure has always focused on awareness, access, and affordability to strengthen women’s health in India. The launch of Galact marks our efforts to redefine and further elevate the standard of women’s health solutions. Our foray into the OTC segment focuses on empowering women across various life stages, starting with a portfolio tailored for their lactation journey. In India, only 64% of mothers breastfeed their babies exclusively in the first 6 months. By making Galact available over the counter, Emcure aims to sensitise all mothers to practice exclusive breastfeeding for the first 6 months in line with the WHO and UNICEF breastfeeding guidelines. Emcure plans to introduce more products under the Galact brand.”
As per UNICEF India figures from 2015, only 65% of infants who are six months old are exclusively breastfed, and only 45% of infants undergo timely initiation of breastfeeding.
The company has a deep ethos of generating awareness around women’s health issues like anemia, menstruation, and breastfeeding. With the launch of its renewed and redesigned Galact brand, Emcure aims to further the cause of breastfeeding and promote optimal nutrition for infants. Also under the Galact brand, Emcure is now ready to launch other products that address the various needs of the lactation phase.
About Emcure Pharmaceuticals Ltd:
Emcure Pharmaceuticals Ltd. (EPL) is an Indian pharmaceutical company headquartered in Pune engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. . Established in 1981, EPL is ranked as the 13th largest pharma company in India in terms of Domestic Sales for MAT September 2023.
